We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Studio Pictures Ltd is a UK-based film and TV production company founded by producers Adam Rolston and David Braithwaite in 2019. Specializing in creating high-quality British entertainment content, the company focuses on adapting books to screen and telling unique true-life stories that entertain and inspire both domestic and international audiences. With successful productions like "A Street Cat Named Bob," the company is building a strong brand and reputation in the industry. Studio Pictures has access to top creative talent and collaborates with major studios like Warner Bros, Sony Pictures, Lionsgate, and Studio Canal. The company is located at Twickenham Studios in Richmond, UK.
days to go: 17 investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PhotoSpotLand allows you to discover great places where, when, how and with whom to shoot great photos. PhotoSpotLand is a helpful location guide for travel photography on the web and on your mobile. Previous explorers have left lots of practical information regarding their experiences on PhotoSpotLand's website.
days to go: Expired investment: £26,924
Fubar radio is a digital media entertainment brand that reaches millions of 18-34 year olds using original video, audio and social media content. Furbar Radio produces edgy and fun content thats available everywhere and on any device.
days to go: Expired investment: £307,250
TOTM makes organic, eco-friendly & reusable period care products. The company is planning to shake up the £29 billion Femcare industry, with 30k+ online and subscription customers, and listings in Tesco, Superdrug and Urban Outfitters and global B2B clients. Having supplied to large corporates including several global institutions, TOTM is ready for global disruption. To this end, the company is raising funds to accelerate global growth across all channels. The proceeds will also be used to expand its product range, grow awareness, secure more distribution and also invest in tech. 

Pitch Rated

77%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £811,400
Helping SME home builders acquire finance for their projects in the UK. Rubicon Capital has assisted more than 40 project developers in receiving investments for their builds, which has exceeded £75m. In their second year, the company generated £500k in profits and has successfully paid dividends every year since launching in 2015. Two main sources of revenue are upfront fees for connecting borrowers with lenders and administration fees in the form of long-term consultancy and performance assistance. Money raised from this crowdfunding round will be used to expand the Rubicon Capital team and grow their business to attract more home builders requiring financial assistance, in addition to increasing the number of sources offering finance.
days to go: Expired investment: £128,510
The developer has secured full planning consent for the demolition of an old milk processing factory and development of 49 residential units and one commercial unit, pre-let to the Co-op on a 15 year lease. The residential development will comprise 39 private units (1 bed flats, 2 bed maisonettes, 3 and 4 bed houses) and 10 affordable units where a sale has already been pre-agreed. The scheme will also include car parking, cycle storage and landscaping. 
days to go: Expired investment: Withheld
Grabr is a social platform that connects users with their passions such as; wine, books, cars etc. Grabr's first site Games Grabr, is a social platform for gamers that allows users to showcase the games they're currently playing/ favourite games. They soon followed with another site called Book Grabr, which did very much the same think but for book lovers.
days to go: Expired investment: £120,440
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph